Wang Yanni相关文献与解析，生知库 | 链接生命科学的每一步

Exploring histone acetylation in ischemic stroke: CREBBP and CKAP4 as candidate biomarkers linked to histone acetylation networks

探索缺血性卒中中的组蛋白乙酰化：CREBBP 和 CKAP4 作为与组蛋白乙酰化网络相关的候选生物标志物

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2026.1727813

Wang, Yanni; Yang, Fan; Tan, Jiaojiao; Guo, Zhentao

Computational Study on Potentially Active Antibacterial Compounds in Secondary Metabolites of Extremophilic Microorganisms

极端微生物次级代谢产物中潜在活性抗菌化合物的计算研究

期刊:ChemistryOpen

影响因子:3.1

doi:10.1002/open.202500460

Li, Dilong; Wang, Yanni; Huang, Yinhuan; Zhou, Hui; Xia, Xiaoyun; Huang, Wei; Wang, Chaojie

The Positive Feedback Loop of Hypoxia-Inducible Factor-1 α /miR-295/Factor Inhibiting Hypoxia-Inducible Factor-1 in Hyperuricemic Nephropathy

高尿酸血症肾病中缺氧诱导因子-1α/miR-295/缺氧诱导因子-1抑制因子的正反馈环路

期刊:Kidney360

影响因子:3

doi:10.34067/KID.0000001069

Li, Jiachang; Ma, Yuhan; Wang, Yanni; Chen, Yizhi; Wei, JiaLi

发表日期：2026

文献求助收藏

Intranasal esketamine plus dexmedetomidine versus dexmedetomidine alone for emergence delirium in pediatric patients: a systematic review and meta-analysis of randomized controlled trials

鼻内注射艾司氯胺酮联合右美托咪定与单独使用右美托咪定治疗儿童患者苏醒期谵妄的疗效比较：一项随机对照试验的系统评价和荟萃分析

期刊:BMC Anesthesiology

影响因子:2.6

doi:10.1186/s12871-026-03628-y

Wang, Yanni; Liu, Cibao; Wu, Yefei; Liu, Qiyuan; Xu, Zeru; Jiang, Xue; Gu, Enmei; Li, Zixuan; Wang, Xiaoliang; Yao, Hao

发表日期：2026

文献求助收藏

Seasonal Dietary Changes Drive Adaptive Responses in the Gut Microbiota and Function of Myotis chinensis

季节性饮食变化驱动中华鼠耳蝠肠道菌群和功能的适应性反应

期刊:Ecology and Evolution

影响因子:2.3

doi:10.1002/ece3.73281

Xiong, Ruohan; Li, Jing; Wang, Ke; Kong, Hongying; Dai, Zhengyu; Wang, Yanni; Zheng, Rongquan

A Fall Prevention Program Integrated in Primary Health Care for Older People in Rural China: The FAMILY Cluster Randomized Clinical Trial

一项融入中国农村老年人基层医疗的防跌倒项目：FAMILY整群随机临床试验

期刊:Journal of the American Medical Association

影响因子:55

doi:10.1001/jama.2025.12724

Peng, Junyi; Ye, Pengpeng; Nan, Boya; Yan, Shichun; Li, Zhifang; Li, Qian; Meng, Ruilin; Li, Yangchun; Hao, Tianyou; Zhang, Lan; Peng, Dandan; Xu, Zijian; Wang, Yanni; Si, Lei; Yang, Minghui; Yao, Yao; Zhang, Jing; Tian, Wei; Wang, Yongchen; Ivers, Rebecca; Tian, Maoyi

发表日期：2025

文献求助收藏

Reply to: "NOTCH1: A Potential New Biomarker in the Era of Immunotherapy?" and "Caution in Interpreting NOTCH1 Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma"

回复：“NOTCH1：免疫治疗时代潜在的新生物标志物？”和“谨慎解读NOTCH1突变作为食管鳞状细胞癌替雷利珠单抗疗效预测生物标志物”

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO-25-01535

Lu, Zhihao; Du, Wenting; Jiao, Xi; Wang, Yanni; Zhang, Zhang; Shen, Lin

NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial.

NOTCH1 突变与替利珠单抗治疗晚期或转移性食管鳞状细胞癌的生存分析：来自随机 III 期 RATIONALE-302 试验的生物标志物分析

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO-24-01818

Lu Zhihao, Du Wenting, Jiao Xi, Wang Yanni, Shi Jingwen, Shi Yang, Shu Yongqian, Niu Zuoxing, Hara Hiroki, Wu Jun, Hsu Chih-Hung, Van Cutsem Eric, Brock Malcolm V, Zhang Zhang, Ding Ningning, Zhang Yun, Shen Zhirong, Shen Lin

An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinoma

基于真实临床特征的晚期食管鳞状细胞癌免疫治疗综合预后预测模型

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-025-03963-y

Dong, Liyuan; Ma, Yue; Cao, Guang; Chen, Dongze; Dong, Fengxiao; Jiao, Xi; Cao, Yanshuo; Liu, Chang; Wang, Yanni; Zhuo, Na; Wang, Fengyuan; Guo, Yixuan; Dai, Tingting; Zhang, Shuwei; Jiao, Hao; Zou, Xingyue; Li, Jian; Shen, Lin; He, Zhonghu; Zhang, Yanqiao; Lu, Zhihao

A large-scale profiling study of immune-coagulation associations in rheumatoid arthritis

一项关于类风湿性关节炎中免疫凝血关联的大规模分析研究

Exploring histone acetylation in ischemic stroke: CREBBP and CKAP4 as candidate biomarkers linked to histone acetylation networks

探索缺血性卒中中的组蛋白乙酰化：CREBBP 和 CKAP4 作为与组蛋白乙酰化网络相关的候选生物标志物

Computational Study on Potentially Active Antibacterial Compounds in Secondary Metabolites of Extremophilic Microorganisms

极端微生物次级代谢产物中潜在活性抗菌化合物的计算研究

The Positive Feedback Loop of Hypoxia-Inducible Factor-1 α /miR-295/Factor Inhibiting Hypoxia-Inducible Factor-1 in Hyperuricemic Nephropathy

高尿酸血症肾病中缺氧诱导因子-1α/miR-295/缺氧诱导因子-1抑制因子的正反馈环路

Intranasal esketamine plus dexmedetomidine versus dexmedetomidine alone for emergence delirium in pediatric patients: a systematic review and meta-analysis of randomized controlled trials

鼻内注射艾司氯胺酮联合右美托咪定与单独使用右美托咪定治疗儿童患者苏醒期谵妄的疗效比较：一项随机对照试验的系统评价和荟萃分析

Seasonal Dietary Changes Drive Adaptive Responses in the Gut Microbiota and Function of Myotis chinensis

季节性饮食变化驱动中华鼠耳蝠肠道菌群和功能的适应性反应

A Fall Prevention Program Integrated in Primary Health Care for Older People in Rural China: The FAMILY Cluster Randomized Clinical Trial

一项融入中国农村老年人基层医疗的防跌倒项目：FAMILY整群随机临床试验

Reply to: "NOTCH1: A Potential New Biomarker in the Era of Immunotherapy?" and "Caution in Interpreting NOTCH1 Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma"

回复：“NOTCH1：免疫治疗时代潜在的新生物标志物？”和“谨慎解读NOTCH1突变作为食管鳞状细胞癌替雷利珠单抗疗效预测生物标志物”

NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial.

NOTCH1 突变与替利珠单抗治疗晚期或转移性食管鳞状细胞癌的生存分析：来自随机 III 期 RATIONALE-302 试验的生物标志物分析

An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinoma

基于真实临床特征的晚期食管鳞状细胞癌免疫治疗综合预后预测模型